ARQULE INC License Agreements
6 Contracts & Agreements
- License Agreement by and between the Company and Basilea Pharmaceutica International Limited, dated April 16, 2018 (Filed With SEC on August 1, 2018)
- License Agreement, dated February 2, 2018, by and among ArQule, Inc., Sinovant Sciences Ltd. and Roivant Sciences Ltd (Filed With SEC on March 5, 2018)
- LICENSE, CO-DEVELOPMENT AND CO-COMMERCIALIZATION AGREEMENT BY AND BETWEEN ARQULE, INC. and DAIICHI SANKYO CO., LTD December 18, 2008 (Filed With SEC on March 6, 2009)
- COLLABORATIVE RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT between ARQULE, INC. and DAIICHI SANKYO CO., LTD November 7, 2008 (Filed With SEC on March 6, 2009)
- Ex-10.12 Amend. No.1 to Compound Supply and License Agreement (Filed With SEC on March 16, 2005)
- AMENDED AND RESTATED R&D LICENSE AGREEMENT (Filed With SEC on March 12, 2004)
